We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSE
1476
DELISTED
Trinseo
TSE
| $871K | ﹤0.01% |
+22,644
| New | +$1.03M |
|
1477
Federal Realty Investment Trust
FRT
$10.1B
| $867K | ﹤0.01% |
9,110
+960
| +12% | +$108K |
|
1478
Alnylam Pharmaceuticals
ALNY
$29.6B
| $865K | ﹤0.01% |
6,014
-5,233
| -47% | -$742K |
|
1479
Bankunited
BKU
$3.35B
| $865K | ﹤0.01% |
+24,332
| New | +$964K |
|
1480
Kadant
KAI
$4B
| $865K | ﹤0.01% |
4,745
-51
| -1% | -$9.5K |
|
|
HAYN
1481
DELISTED
Haynes International, Inc.
HAYN
| $863K | ﹤0.01% |
26,347
-20,151
| -43% | -$781K |
|
1482
Central Garden & Pet Co Class A
CENTA
$2.4B
| $857K | ﹤0.01% |
26,770
-3,686
| -12% | -$121K |
|
|
AEL
1483
DELISTED
American Equity Investment Life Holding Company
AEL
| $856K | ﹤0.01% |
23,398
-1,162
| -5% | -$44.2K |
|
|
EQC
1484
DELISTED
Equity Commonwealth
EQC
| $855K | ﹤0.01% |
31,167
+15,190
| +95% | +$410K |
|
1485
DigitalBridge
DBRG
$2.95B
| $854K | ﹤0.01% |
43,748
-44,479
| -50% | -$1.09M |
|
1486
Camden National
CAC
$982M
| $853K | ﹤0.01% |
19,360
-1,752
| -8% | -$78.6K |
|
1487
Funko
FNKO
$332M
| $851K | ﹤0.01% |
38,109
-24,413
| -39% | -$472K |
|
1488
Luxfer Holdings
LXFR
$457M
| $851K | ﹤0.01% |
56,291
-1,615
| -3% | -$26.1K |
|
|
NEWR
1489
DELISTED
New Relic, Inc.
NEWR
| $851K | ﹤0.01% |
+17,575
| New | +$976K |
|
|
BBT
1490
Beacon Financial Corp
BBT
$2.66B
| $849K | ﹤0.01% |
34,277
+12,568
| +58% | +$326K |
|
1491
Box
BOX
$4.55B
| $846K | ﹤0.01% |
33,635
-82,199
| -71% | -$2.3M |
|
1492
CareTrust REIT
CTRE
$9.14B
| $846K | ﹤0.01% |
45,874
-22,388
| -33% | -$397K |
|
1493
Victory Capital Holdings
VCTR
$6.99B
| $839K | ﹤0.01% |
34,832
+2,422
| +7% | +$65.2K |
|
1494
TTEC Holdings
TTEC
$84.2M
| $835K | ﹤0.01% |
12,300
-1,149
| -9% | -$80.7K |
|
1495
Myriad Genetics
MYGN
$308M
| $832K | ﹤0.01% |
45,808
-33,041
| -42% | -$686K |
|
|
NTUS
1496
DELISTED
Natus Medical Inc
NTUS
| $830K | ﹤0.01% |
25,334
-18,821
| -43% | -$595K |
|
1497
Agree Realty
ADC
$9.13B
| $827K | ﹤0.01% |
11,468
+2,369
| +26% | +$164K |
|
|
ENV
1498
DELISTED
ENVESTNET, INC.
ENV
| $823K | ﹤0.01% |
15,637
-39,173
| -71% | -$2.68M |
|
|
CD
1499
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
| $821K | ﹤0.01% |
+105,810
| New | +$682K |
|
1500
Oportun Financial
OPRT
$350M
| $813K | ﹤0.01% |
98,283
+12,554
| +15% | +$145K |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.